Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $10.81 in the prior trading day, UiPath Inc (NYSE: PATH) closed at $11.21, up 3.70%. In other words, the price has increased by $3.70 from its previous closing price. On the day, 8.6 million shares were traded. PATH stock price reached its highest trading level at $11.21 during the session, while it also had its lowest trading level at $10.825.
Ratios:
Our goal is to gain a better understanding of PATH by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.78 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.16. For the most recent quarter (mrq), Quick Ratio is recorded 3.01 and its Current Ratio is at 2.82. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Macquarie Downgraded its Outperform to Neutral on June 03, 2024, whereas the target price for the stock was revised from $29 to $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 25 ’25 when Ramani Hitesh sold 12,500 shares for $12.68 per share. The transaction valued at 158,449 led to the insider holds 256,921 shares of the business.
HITESH RAMANI bought 12,500 shares of PATH for $165,500 on Feb 25 ’25. On Jan 03 ’25, another insider, Ramani Hitesh, who serves as the Chief Accounting Officer of the company, sold 25,000 shares for $13.05 each. As a result, the insider received 326,162 and left with 269,421 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PATH now has a Market Capitalization of 6161004544 and an Enterprise Value of 4620838912. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.31 while its Price-to-Book (P/B) ratio in mrq is 3.56. Its current Enterprise Value per Revenue stands at 3.232 whereas that against EBITDA is -38.312.
Stock Price History:
The Beta on a monthly basis for PATH is 1.02, which has changed by -0.50638485 over the last 52 weeks, in comparison to a change of 0.10838497 over the same period for the S&P500. Over the past 52 weeks, PATH has reached a high of $23.64, while it has fallen to a 52-week low of $9.50. The 50-Day Moving Average of the stock is -13.91%, while the 200-Day Moving Average is calculated to be -12.07%.
Shares Statistics:
The stock has traded on average 10.27M shares per day over the past 3-months and 18846720 shares per day over the last 10 days, according to various share statistics. A total of 549.60M shares are outstanding, with a floating share count of 409.96M. Insiders hold about 25.41% of the company’s shares, while institutions hold 52.79% stake in the company. Shares short for PATH as of 1740700800 were 33563297 with a Short Ratio of 3.27, compared to 1738281600 on 31851059. Therefore, it implies a Short% of Shares Outstanding of 33563297 and a Short% of Float of 7.920000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
